ANNOUNCEMENT 25 Mar 2020

India has banned the export of the drug hydroxychloroquine and its formulations.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising
Inception date: 25 Mar 2020 | Removal date: 17 Jun 2020

Export ban

On 25 March 2020, the Indian Directorate General of Foreign Trade through Notification No. 54/2015-2020 prohibited the exports of Hydroxychloroquine and Formulations made from Hydroxychloroquine.

However, exports will be allowed under 3 conditions - 

  • Exports from Special Economic Zones and Export Processing Units and exports made to fulfill export obligations on a license issued before 25 March 2020
  • Exports in cases where an Irrevocable Letter of Credit has been issued before 25 March 2020 or if a full advance has been received by the exporter against a specific shipment
  • Exports allowed by the Government of India on humanitarian grounds on a case by case basis

On 4 April 2020, the above exceptions on export were removed and a complete ban was notified (please see related State Act).

On 7 April 2020, the government notified that the exports of Hydroxychloroquine will be permitted through an export license on a case to case basis.

On 18 June 2020, through Notification No. 13/2015-2020 the export prohibition on these products has been withdrawn.

AFFECTED SECTORS

 

AFFECTED PRODUCTS